Reports for BAUSCH HEALTH, CANADA INC.

Company Name

BAUSCH HEALTH, CANADA INC.

Totals

Shortage reports

346

Actual shortage: 11 (3%)
Anticipated shortage: 0 (0%)
Avoided shortage: 34 (10%)
Resolved: 301 (87%)

Discontinuation Reports

13

To be discontinued: 1 (8%)
Discontinued: 12 (92%)
Reversed: 0 (0%)

Late reports

96 (27%)

Overdue reports

1 (8%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
SUBLINOX 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2018-03-02 2018-06-20 41546
SUBLINOX 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2021-06-02 2021-11-30 140229
SUBLINOX 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2018-03-02 2018-06-30 41543
SUBLINOX 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-06-12 2019-07-05 86505
SUBLINOX 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-10-10 2019-10-17 96014
SUBLINOX 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2021-10-05 2021-12-09 146697

Showing 341 to 346 of 346

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
LIDEX 0.05% CREAM Discontinued 2023-12-08 2023-12-08 212804
VITAMIN A ACID 0.05% GEL Discontinued 2024-01-30 2024-02-08 217843
VITAMIN A ACID 0.01% GEL To be discontinued 2024-01-30 2024-01-30 217835
VITAMIN A ACID 0.025% GEL Discontinued 2024-01-30 2024-02-08 217848
AIROMIR 100MCG METERED-DOSE AEROSOL Discontinued 2023-11-29 2023-11-29 211859
LODALIS 3.75G POWDER FOR SUSPENSION Discontinued 2023-12-08 2024-02-20 212799
DELATESTRYL 200MG SOLUTION Discontinued 2024-03-11 2024-04-26 221772
THEOLAIR 80MG SOLUTION Discontinued 2021-04-26 2021-04-27 138081
ALTACE HCT 12.5MG 2.5MG TABLET Discontinued 2023-12-21 2024-01-09 214011
ALTACE HCT 12.5MG 5MG TABLET Discontinued 2023-12-21 2024-01-09 214014
ALTACE HCT 12.5MG 10MG TABLET Discontinued 2023-12-21 2024-01-09 214024
ALTACE HCT 25MG 5MG TABLET Discontinued 2023-12-21 2024-01-09 214017
ALTACE HCT 25MG 10MG TABLET Discontinued 2023-12-21 2024-01-09 214027

Showing 1 to 13 of 13